(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: ... to take charge of their health at home through the ... dividend of $3.00 per share on its Series B Convertible ... in shares of Series B stock in an amount per ...
(Date:12/2/2009)... COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: ... results of its fourth quarter and fiscal year 2009 on ... Following the release, at 4:45 p.m. ET Martek will ... All interested parties may listen to the call live ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... The world,s first concept demonstration tires made ... petrochemically produced ingredient in the manufacture of synthetic rubber ... this week. One tire will be on display at ... Copenhagen International Airport throughout December 21, while the other ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3... GeneNews Limited (TSX: GEN), a,company focused on developing ... and personalized health management, today announced,management changes to ... Effective May 31, 2008, Dr. K. Wayne ... on new duties as Chief Clinical Scientist for ...
... 2 Perceptive Informatics, the,technology subsidiary of ... announced that it has integrated its leading ... a specialized image,management and reporting system provided ... cardiac function assessment in clinical studies.,The system ...
... Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announced that interim ... in patients with sarcomas metastatic to the lung,were ... Oncology,(ASCO) annual meeting. The presentation, entitled "A Phase ... Treatment of Patients with,Bone and Soft Tissue Sarcomas ...
Other Biology Technology:GeneNews announces management changes to support commercialization of ColonSentry(TM) 2Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function 2Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function 3Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function 4Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 2...
[14C]Polyethylene glycol 4000, 9.25 MBq, 250 uCi. Aqueous solution containing 3% ethanol, sterilized. 370-740 MBq/g, 10-20 mCi/g.1.85 MBq/ml, 50 uCi/ml. Category: Radiochemicals &Radiation Safety, ...
Use the DUALmembrane kit 3 to carry out DUALmembrane interaction analysis and cDNA library screening to characterize interactions between integral membrane proteins and to identify novel interaction ...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Biology Products: